Simplex Trading
NRIX icon

Simplex Trading’s Nurix Therapeutics NRIX Stock Holding History

Simplex Trading’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,113
Closed -$138K – 9988
2026
Q1 		$126K Sell
8,113
-15,772
-66% -$262K ﹤0.01% 4816
2025
Q4 		$453K Buy
23,885
+9,440
+65% +$136K ﹤0.01% 3398
2025
Q3 		$133K Buy
+14,445
New +$150K ﹤0.01% 5428
2024
Q4 		– Sell
-832
Closed -$19.1K – 9277
2024
Q3 		$18K Sell
832
-1,374
-62% -$31.1K ﹤0.01% 6753
2024
Q2 		$46K Sell
2,206
-2,419
-52% -$37.7K ﹤0.01% 6177
2024
Q1 		$67K Buy
4,625
+4,558
+6,803% +$49K ﹤0.01% 5991
2023
Q4 		$0 Sell
67
-1,041
-94% -$7.13K ﹤0.01% 9483
2023
Q3 		$8K Sell
1,108
-4,702
-81% -$42.9K ﹤0.01% 7342
2023
Q2 		$58K Buy
+5,810
New +$59.2K ﹤0.01% 5696
2023
Q1 		– Sell
-100
Closed -$1.04K – 9779
2022
Q4 		$1K Sell
100
-100
-50% -$1.21K ﹤0.01% 8873
2022
Q3 		$2K Buy
200
+193
+2,757% +$3.06K ﹤0.01% 9320
2022
Q2 		$0 Sell
7
-13
-65% -$147 ﹤0.01% 10710
2022
Q1 		$0 Buy
+20
New +$355 ﹤0.01% 11084
2021
Q4 		– Sell
-299
Closed -$9.06K – 11106
2021
Q3 		$8K Hold
299
– – ﹤0.01% 9058
2021
Q2 		$7K Buy
299
+199
+199% +$5.84K ﹤0.01% 9289
2021
Q1 		$3K Buy
+100
New +$3.78K ﹤0.01% 8379

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's NRIX Position: Q2 2026 in Review

Simplex Trading sold out of Nurix Therapeutics (NRIX) in Q2 2026, closing a stake of 8,113 shares — an estimated $138K sold.

Simplex Trading first reported a position in NRIX in Q1 2021 and held it in 16 quarters. The position peaked at $453K in Q4 2025. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Simplex Trading reported no remaining Nurix Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 8,113 Nurix Therapeutics shares in Q2 2026, an estimated $138K.
  • Simplex Trading first reported a position in Nurix Therapeutics in Q1 2021 and held it in 16 quarters.
  • Simplex Trading's Nurix Therapeutics position peaked at $453K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.